- $69.72bn
- $79.54bn
- $20.07bn
Penumbra jumps on Boston Scientific's $14.5 billion buyout
Live Markets: Wall Street indexes rise with tech in lead, healthcare falls most
Deals of the day-Mergers and acquisitions
Penumbra jumps on Boston Scientific's $14.5 billion buyout deal
Factbox: Major deals involving U.S. drugmakers and biotechs over the past decade
Boston Scientific to buy Penumbra in $14.5 billion deal (updated)
Penumbra jumps on Boston Scientific's $14.5 billion buyout deal
Boston Scientific to buy Penumbra in deal valued at $14.5 billion
Newscasts - CIO sees healthcare as a great potential investment in 2026
Medtech: Clear split between gainers and losers in 2025
U.S. RESEARCH ROUNDUP-Airbnb, Garrett Motion, Range Resources
Medtronic, Abbott fall after CDMO cites slow adoption of some heart and nerve devices
U.S. RESEARCH ROUNDUP-Avery Dennison, Expedia Group, Hologic
U.S. STOCKS ON THE MOVE-Mattel, Alphabet, GE Vernova
U.S. STOCKS ON THE MOVE-Healthcare Services Group, Western Alliance, Warner Bros Discovery
Boston Scientific lifts annual profit forecast on strong demand for heart devices (updated)
Boston Scientific up on Q3 results beat, FY profit forecast raise
U.S. STOCKS ON THE MOVE- Avadel Pharma, Amphenol, Applied Digital
U.S. STOCKS ON THE MOVE-Alphabet, Intuitive Surgical, Thermo Fisher